Benperidol
Benperidol structure
|
Common Name | Benperidol | ||
|---|---|---|---|---|
| CAS Number | 2062-84-2 | Molecular Weight | 381.44 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C22H24FN3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BenperidolBenperidol is a relatively old antipsychotic drug. Benperidol is a butyrophenone antipsychotic, with the highest neuroleptic potency in terms of D2 receptor blockade[1]. |
| Name | Benperidol |
|---|---|
| Synonym | More Synonyms |
| Description | Benperidol is a relatively old antipsychotic drug. Benperidol is a butyrophenone antipsychotic, with the highest neuroleptic potency in terms of D2 receptor blockade[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Leucht S, et al. Benperidol for schizophrenia. Cochrane Database Syst Rev. 2005;2005(2):CD003083. |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H24FN3O2 |
| Molecular Weight | 381.44 |
| Exact Mass | 381.185242 |
| PSA | 58.10000 |
| LogP | 4.09 |
| Vapour Pressure | 7.96E-17mmHg at 25°C |
| Index of Refraction | 1.595 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
|
~%
Benperidol CAS#:2062-84-2 |
| Literature: US3936468 A1, ; |
![3-[1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-yl]-1H-benzimidazol-2-one structure](https://image.chemsrc.com/caspic/213/34104-74-0.png)
| Precursor 2 | |
|---|---|
| DownStream 0 | |
|
Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.
Eur. J. Nucl. Med. Mol. Imaging 35(4) , 771-8, (2008) N-([(11)C]methyl)benperidol ([(11)C]NMB) can be used for positron emission tomography (PET) measurements of D(2)-like dopamine receptor binding in vivo. We report the absorbed radiation dosimetry of i... |
|
|
Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.
Nucl. Med. Biol. 24(4) , 311-8, (1997) Radiation absorbed doses due to IV administration of [18F](N-methyl) benperidol ([18F]NMB) were estimated by whole-body PET imaging of nonhuman primates. Time-activity curves were obtained for nine co... |
|
|
Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
Nucl. Med. Biol. 35(3) , 335-41, (2008) Positron emission tomography measurements of dopaminergic D2-like receptors may provide important insights into disorders such as Parkinson's disease, schizophrenia, dystonia and Tourette's syndrome. ... |
| 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]piperidin-4-yl]-2-benzimidazolinone |
| R 4584 |
| 1-[1-[3-(p-fluorobenzoyl)propyl]-4-piperidyl]-2-benzimidazolinone |
| 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro- |
| EINECS 218-172-2 |
| 1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one |
| 1-{1-[4-(4-Fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one |
| Frenactil |
| Benzeridol |
| Benperidol |
| MFCD00866672 |
| Glianimon |
| Anquil |
| 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro- |
| Frenactyl |
| 8089c.b. |
| Concilium |
| 1-{1-[4-(4-Fluorophenyl)-4-oxobutyl]-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one |